Patents by Inventor Evan Abrahamse

Evan Abrahamse has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230380438
    Abstract: The invention concerns a native whey protein composition with profound amounts of native whey protein and with beta-casein for use in the treatment and/or prevention of gastrointestinal intolerance. The inventors found that the native whey protein composition relatively high in beta-casein and low in kappa- and alpha-casein provides a beneficial effect on gastrointestinal intolerance.
    Type: Application
    Filed: October 27, 2021
    Publication date: November 30, 2023
    Applicant: N.V. Nutricia
    Inventors: Ingrid Brunhilde Renes, Evan Abrahamse, Gerrit Hols
  • Patent number: 11490631
    Abstract: An infant formula for preventing gastro-esophageal reflux is disclosed comprising whey protein and/or casein, a galactomannan thickener, and a fermented milk-derived product.
    Type: Grant
    Filed: March 18, 2020
    Date of Patent: November 8, 2022
    Assignee: N.V. NUTRICIA
    Inventors: Marie Thomas, Francis Lecroix, Evan Abrahamse, Houkje Bouritius
  • Publication number: 20220016204
    Abstract: The invention concerns native whey protein for use in (a) improving intestinal maturation; and/or (b) reducing and/or preventing intestinal permeability. The inventors found that native whey protein provides a beneficial effect on intestinal maturation and permeability.
    Type: Application
    Filed: February 3, 2020
    Publication date: January 20, 2022
    Applicant: N.V. Nutricia
    Inventors: Ingrid Brunhilde Renes, Rudolph Eduardus Maria Verdurmen, Gerrit Hols, Evan Abrahamse
  • Publication number: 20210401894
    Abstract: The invention concerns native whey protein for use in the treatment and/or prevention of intestinal infection or inflammation, in particular necrotizing enterocolitis. The inventors found that native whey protein provides a beneficial effect on intestinal infection or inflammation.
    Type: Application
    Filed: February 3, 2020
    Publication date: December 30, 2021
    Applicant: N.V. Nutricia
    Inventors: Ingrid Brunhilde Renes, Rudolph Eduardus Maria Verdurmen, Gerrit Hols, Evan Abrahamse
  • Patent number: 11116233
    Abstract: The invention pertains to a process for simultaneous producing an infant formula product and an acidic dairy product from defatted animal milk, comprising (a) processing the milk into a casein stream, a whey protein stream and a lactose stream, by: (i) subjecting the defatted animal milk to a filtration step over a microfiltration membrane capable of retaining bacteria and permeating milk proteins, to provide a debacterialized milk as permeate; (ii) subjecting the permeate originating from step (i) to a filtration step over a microfiltration membrane capable of retaining casein and permeating whey proteins, to provide a casein stream as retentate and a permeate comprising whey protein; (iii) fractionating the permeate originating from step (ii) into a whey protein stream and a lactose stream; (b) combining part of the casein stream, at least part of the whey protein stream originating from step (a) and a lactose source to obtain a recombined stream, wherein the lactose source comprises acid whey; (c) using th
    Type: Grant
    Filed: August 8, 2017
    Date of Patent: September 14, 2021
    Assignees: Compagnie Gervais Danone, N.V. Nutricia
    Inventors: Franck David, Claire Queguiner, Laurent Schmitt, Gerrit Hols, John Tobin, Raoul Charles Johan Moonen, Evelien Louise Van Eijk-Van Boxtel, Evan Abrahamse
  • Patent number: 10602752
    Abstract: An infant formula for preventing gastro-esophageal reflux is disclosed comprising whey protein and/or casein, a galactomannan thickener, and a fermented milk-derived product.
    Type: Grant
    Filed: April 15, 2010
    Date of Patent: March 31, 2020
    Assignee: N.V. NUTRICIA
    Inventors: Marie Thomas, Francis Lecroix, Evan Abrahamse, Houkje Bouritius
  • Patent number: 9717270
    Abstract: The present invention relates to a fermented infant formulae comprising non digestible oligosaccharides for improving intestinal tract health by decreasing protein digestive effort, by decreasing the amount of endogenously formed proteases concomitant with an increased protein digestion, and a reduced protein fermentation.
    Type: Grant
    Filed: February 24, 2017
    Date of Patent: August 1, 2017
    Assignee: N.V. Nutricia
    Inventors: Thomas Ludwig, Sylvie Huybers, Evan Abrahamse, Houkje Bouritius
  • Patent number: 9617327
    Abstract: The present invention relates to a fermented infant formulae comprising non digestible oligosaccharides for improving intestinal tract health by decreasing protein digestive effort, by decreasing the amount of endogenously formed proteases concomitant with an increased protein digestion, and a reduced protein fermentation.
    Type: Grant
    Filed: June 14, 2013
    Date of Patent: April 11, 2017
    Assignee: N.V. Nutricia
    Inventors: Thomas Ludwig, Sylvie Huybers, Evan Abrahamse, Houkje Bouritius
  • Patent number: 9307780
    Abstract: A sterilized food product containing starch, the starch having: (a) an amylose content of at least 60 wt. %; (b) a median particle size of between 1 and 15 ?m, at least 90 wt. % of the starch particles having a particle diameter of less than 50 ?m; and (c) a non-digestible starch content of less than 50 wt. %. The product is obtained by heating and rapidly cooling the starch product and has a high slowly digestible starch content. It is suitable for use in the treatment of diabetes, obesity, insulin resistance, or for postprandial glucose response.
    Type: Grant
    Filed: January 7, 2014
    Date of Patent: April 12, 2016
    Assignee: N.V. NUTRICIA
    Inventors: Evan Abrahamse, Wynette Hermina Agnes Kiers, Houkje Bouritius, Koenraad Gerard Christoffel Weel
  • Patent number: 9247763
    Abstract: The invention relates to a combination of heat-treated nutritional composition having a carbohydrate fraction comprising a) 5-30 wt % of one or more monosaccharides selected from galactose, ribose and mannose; b) carbohydrates capable of providing b1) sustained release glucose and b2) rapidly available glucose; c) optionally fructose; d) glucose-containing disaccharides other than maltose and sucrose; and e) optionally sugar polyols. The invention also pertains to the use of such a heat-treated nutritional composition for controlling glucose levels in blood and/or tissue, especially for preventing and/or treating diabetics, insulin-resistance, obesity, postprandial glucose response, metabolic syndrome, syndrome X, hyperglycemia, hypertriglyceridemia, hyperinsulinemia, dyslipidemia, dysfibrinolysis and/or disorders associated with major surgery or trauma.
    Type: Grant
    Filed: July 5, 2006
    Date of Patent: February 2, 2016
    Assignee: N.V. Nutricia
    Inventors: Houkje Bouritius, Evan Abrahamse, Wynette Hermina Agnes Kiers, Chantal Severijnen, Katrien Maria Jozefa van Laere, Robert Johan Joseph Hageman
  • Publication number: 20150132365
    Abstract: The present invention relates to a fermented infant formulae comprising non digestible oligosaccharides for improving intestinal tract health by decreasing protein digestive effort, by decreasing the amount of endogenously formed proteases concomitant with an increased protein digestion, and a reduced protein fermentation.
    Type: Application
    Filed: June 14, 2013
    Publication date: May 14, 2015
    Applicant: N.V. Nutricia
    Inventors: Thomas Ludwig, Sylvie Huybers, Evan Abrahamse, Houkje Bouritius
  • Patent number: 8642110
    Abstract: A sterilized food product containing starch, the starch having: (a) an amylose content of at least 60 wt. %; (b) a median particle size of between 1 and 15 &mgr; m, at least 90 wt. % of the starch particles having a particle diameter of less than 50 &mgr; m; and (c) a non-digestible starch content of less than 50 wt. %; and (d) a slowly digestible starch content of 15-75 wt. %. The product is obtained by heating and rapidly cooling the starch product and has a high slowly digestible starch content. It is suitable for use in the treatment of diabetes, obesitas, insulin resistance, or for postprandial glucose response.
    Type: Grant
    Filed: December 28, 2007
    Date of Patent: February 4, 2014
    Assignee: N.V. Nutricia
    Inventors: Evan Abrahamse, Wynette Hermina Agnes Kiers, Houkje Bouritius, Koenraad Gerard Christoffel Weel
  • Publication number: 20130337105
    Abstract: The present invention relates to a fermented infant formulae for decreasing protein digestive effort by decreasing the amount of endogenously formed proteases, concomitant with an increased protein digestion. The invention also relates to low protein fermented infant formulae.
    Type: Application
    Filed: December 5, 2011
    Publication date: December 19, 2013
    Inventors: Thomas Ludwig, Sylvie Huybers, Evan Abrahamse, Houkje Bouritius
  • Publication number: 20120213858
    Abstract: An infant formula for preventing gastro-esophageal reflux is disclosed comprising whey protein and/or casein, a galactomannan thickener, and a fermented milk-derived product.
    Type: Application
    Filed: April 15, 2010
    Publication date: August 23, 2012
    Inventors: Marie Thomas, Francis Lecroix, Evan Abrahamse, Houkje Bouritius
  • Publication number: 20100086668
    Abstract: A sterilised food product containing starch, the starch having: (a) an amylose content of at least 60 wt. %; (b) a median particle size of between 1 and 15 &mgr;m, at least 90 wt. % of the starch particles having a particle diameter of less than 50 &mgr;m; and (c) a non-digestible starch content of less than 50 wt. %; and (d) a slowly digestible starch content of 15-75 wt. %. The product is obtained by heating and rapidly cooling the starch product and has a high slowly digestible starch content. It is suitable for use in the treatment of diabetes, obesitas, insulin resistance, or for postprandial glucose response.
    Type: Application
    Filed: December 28, 2007
    Publication date: April 8, 2010
    Applicant: N.V. NUTRICIA
    Inventors: Evan Abrahamse, Wynette Hermina Agnes Kiers, Houkje Bouritius, Koenraad Gerard Christoffel Weel
  • Publication number: 20090011990
    Abstract: The invention relates to a combination of heat-treated nutritional composition having a carbohydrate fraction comprising a) 5-30 wt % of one or more monosaccharides selected from galactose, ribose and mannose; b) carbohydrates capable of providing b1) sustained release glucose and b2) rapidly available glucose; c) optionally fructose; d) glucose-containing disaccharides other than maltose and sucrose; and e) optionally sugar polyols. The invention also pertains to the use of such a heat-treated nutritional composition for controlling glucose levels in blood and/or tissue, especially for preventing and/or treating diabetics, insulin-resistance, obesity, postprandial glucose response, metabolic syndrome, syndrome X, hyperglycemia, hypertriglyceridemia, hyperinsulinemia, dyslipidemia, dysfibrinolysis and/or disorders associated with major surgery or trauma.
    Type: Application
    Filed: July 5, 2006
    Publication date: January 8, 2009
    Inventors: Houkje Bouritius, Evan Abrahamse, Wynette Hermina Kiers, Chantal Severijnen, Katrien Maria Jozefa van Laere, Robert Johan Hageman